Lamifin Tablet (Terbinafine Hydrochloride)

Adult dose

Administer 125 mg of terbinafine as a single dose twice a day or 250 mg once a day. The treatment period depends on the disease as follows: 1) Dermatophyte infections Tinea pedis (interdigital type, plantar type/moccasin type): 2-6 weeks Tinea corporis: 2-4 weeks Tinea cruris (jock itch): 2-4 weeks 2) Onychomycosis Generally administered for 6 weeks to 3 months. If the infection is on the fingernail or relatively small toenail, or in younger patients, the treatment period can be shortened to less than 3 months. For nail infections, a treatment period of 3 months is usually sufficient, but in some patients, it may take 6 months or more. In patients with slow nail growth, the treatment period may be extended.

Child dose

Administered to children over 2 years of age. For those under 2 years, there is insufficient experience to recommend administration. Tinea capitis: 4 weeks 1) Weight under 20 kg (under 5 years): 62.5 mg once.

This drug is not recommended for patients with chronic liver disease or active liver disease. Before using this medication, the patient's liver disease status and history must be confirmed. Liver function abnormalities may occur regardless of liver disease history; therefore, regular liver function tests should be conducted before and during treatment. If liver function test values rise, the use of this medication must be discontinued immediately. If symptoms such as nausea, loss of appetite, fatigue, vomiting, pain in the right upper abdomen, jaundice, dark urine, or diarrhea occur during treatment, the patient must inform a doctor immediately. If these symptoms occur, this drug should be discontinued, and liver function tests should be performed. This medication can rarely cause severe liver failure, which may necessitate death or a liver transplant, so if signs of liver damage appear, treatment must be stopped immediately, and liver function should be monitored regularly. This drug should not be used in patients who have had allergic reactions to this drug or its components, those with chronic or active liver disease, blood disorders, severe renal failure, nursing mothers, or infants under 2 years old. Patients with lactose intolerance should also be cautious about using this medication. Careful administration should be observed for patients with impaired kidney function, elderly individuals, and children weighing less than 20 kg, and treatment should be stopped immediately if severe skin reactions occur. Patients with psoriasis or systemic lupus erythematosus should be cautious when using this medication. Patients should be regularly monitored for liver function, blood tests, skin condition, musculoskeletal symptoms, etc., and must consult with a doctor immediately if any abnormal symptoms occur. It is advisable to avoid driving or operating machinery if symptoms such as dizziness occur during the use of this medication. This medication may interact with other drugs, so if other medications are being taken, the patient must inform their doctor or pharmacist, and dosage adjustments may be necessary. Women of childbearing age should be cautious as there may be menstrual irregularities when used with oral contraceptives, and this medication's safety during pregnancy has not been established, so it should only be used when necessary. Nursing women should stop breastfeeding when taking this medication. In children, particularly those under 2 years of age, there is a lack of experience in administration, so careful consideration is advised, and elderly patients may require caution as the drug can remain in the body longer due to liver and kidney function decline. Overdose may result in headaches, nausea, abdominal pain, and dizziness, and immediate medical attention should be sought for proper treatment. This medication should be kept out of reach of children, not moved to other containers, stored away from direct sunlight, and kept at room temperature.

Serious side effects

Urticaria, facial swelling, lymphadenopathy, liver failure, hepatitis, cholestasis, jaundice, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin eruptions, exfoliative dermatitis, blistering dermatitis, rhabdomyolysis, hypotension, respiratory distress, feelings of chest tightness, anaphylactic reactions (including angioedema and superficial as well as systemic lupus erythematosus), paralysis, severe skin adverse reactions.

Mild side effects

Rash, itching, fever, nausea, vomiting, loss of appetite, fatigue, musculoskeletal reactions (arthralgia, myalgia), muscle pain, weakness, gastrointestinal symptoms (abdominal distention, decreased appetite, dyspepsia, mild abdominal pain, diarrhea), discomfort in the upper stomach, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory loss, decreased attention, insomnia, increased BUN, polyuria, visual disturbances, tinnitus, elevated total cholesterol in the blood.

This medication should be stored in an airtight, sealed container and kept at a temperature between 1 to 30 degrees Celsius. Storing it this way can maintain the drug's efficacy for a longer period.

Appearance

White to off-white round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle